Ä¢¹½ÊÓÆµ

Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist ¡°Tirzepatide¡±

July 7, 2022

Mitsubishi Tanabe Pharma Corporation, a member of the Ä¢¹½ÊÓÆµ, has announced the following press release.

¡öMitsubishi Tanabe Pharma¡¡Press Release
Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist “Tirzepatide”


?Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point.

Back to top